Supreme Court Refuses to Review 9th Cir.’s Reinstatement of Remicade Cancer Suit



DOCUMENTS
  • 9th Circuit Opinion


WASHINGTON, D.C. — The U.S. Supreme Court has refused to review a federal appeals court’s reinstatement of a case against Teva Pharmaceuticals USA Inc. in which plaintiffs allege their son’s cancer was caused by combining Purinethol with Remicade and Humira.

The high court denied Teva’s petition for certiorari on March 19. The pharmaceutical maker sought to challenge the 9th Circuit U.S. Court of Appeal’s ruling that the trial court erred in excluding the testimony of the plaintiffs’ experts.

Stephen and Lisa Wendell sued Teva Pharmaceuticals Inc. and Par Pharmaceuticals Inc. in California state court, alleging their deceased son, Maxx, developed …

FIRM NAMES
  • Ulmer & Berne
  • Williams Cuker Berezofsky





UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS